Emerging drug innovation in China influences global patient access, highlighting shifts in the pharmaceutical landscape.
China has recently emerged as an important player in new drug development — a field traditionally dominated by the United States and Europe. This shift has implications for global access to new medicines.
No takes yet. Share an insight, caveat, or question.
Vokinger et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: